prcRoosterReplenishTM-MSC-CC is a xeno-free (XF), GMP concentrated bioreactor feed for use in fed-batch hMSC manufacturing bioreactor processes to eliminate media exchanges during rapid expansion of human MSCs for clinical allogeneic and autologous therapeutic cell manufacturing.
Engineered to achieve high cell growth in scalable (>50L) microcarrier-based suspension cultures when paired with our CC RoosterVial™-MSCs and prcRoosterNourish-MSC-CC while reducing contamination risks associated with in-process manipulation. prcRoosterReplenish-MSC-CC boosts media productivity (millions of cells produced per Liter of media consumed) by up to 70%, with each 100 ml bagged unit supplementing 5L of bioreactor expansion media.
CliniControl™ bioprocess media are manufactured with methods and controls that conform with current Good Manufacturing Practices (cGMP) and are supported for use as an ancillary material by a Type II Master File on file with the FDA. Time spent on investigational new drug (IND) submissions is significantly reduced by facilitating CMC documentation.
Product Features
Xeno-free | cGMP | Pathogen Reduced (prc)*
Enables a fed-batch process for scalable (>50L) 3D bioreactor hMSC culture.
Eliminate media exchange by addition on Day 3 of bioreactor culture.
Streamlines culture processes & reduces processing time and labor.
Maintains stable nutrient and waste bio-profiles through 7 days of culture; comparable to batch culture.
Mitigates risk of contamination by minimizing in-process culture manipulation.
Available in custom high-volume bagged and non ‘prc’ formulations.
Supported by US FDA Type II Master Files – available for cross reference
Intended Use: For Further Manufacturing Use Only. Not intended for diagnostic use or as an excipient for direct human or veterinary therapeutic use.
*’prc’ denoted products have been manufactured using pathogen reduced components to meet evolving regulatory needs and standards.
Fig 1: A comparison of XF hMSC cell densities in bioreactor culture using batch and fed-batch processes. RoosterVial™-hBM-XF (Xeno-free human bone marrow-derived mesenchymal stem cells – RoosterVial™-hBM-10M-XF – were cultured in suspension on microcarriers in RoosterNourish™-MSC-XF and fed with RoosterReplenish™-MSC-XF on Day 3, and compared to batch culture.
Fig 2: Fed-batch culture using RoosterReplenish™-MSC-XF is the most efficient and productive culture feeding regimen, outperforming either 1/2 media exchange or batch culture in media productivity by over 70%, and achieving up to 350 million (M) cells/L. This productivity is >17 times the media productivity of traditional hMSC flask-based cultures of ~20M cells/L, and is the central driving force for cost reduction in bioreactor-based manufacturing. Note: Total cell yield is donor-dependent.
